Latest news with #BS6
NDTV
4 days ago
- Automotive
- NDTV
Tata Motors To Equip Harrier, Safari With More Powerful FAM B 2.0-Litre Diesel Engine
Tata Motors is now planning to give the Harrier and Safari a new engine, while not much change is expected, the tuned engine will give more power to the SUVs. The stricter BS6 norms pushed Tata to get a tuned 2.2-liter diesel engine for its commercial vehicle lineup. Tata then took assistance from Stellantis to get the FAM B 2.0-liter engine for the Harrier and the Safari. However, now the homegrown auto major has acquired the license to work on the engines for development. While Tata Motors has acquired the license for the development of the engine, it must be noted that the FAM B 2 engine will be produced by Fiat India Automobile Pvt. Ltd., a joint venture of Tata Motors and Stellantis. The FIATPL facility is located at Ranjangaon, Pune (Maharashtra). According to Autocar, after receiving the development rights for the engines, Tata will get a huge benefit as it can now upgrade engines on different levels, and that too in a cost-effective deal. Earlier, a minor change and upgrade in the engine would cost Tata Motors around 10 million Euros, which converts to about Rs 96.9 crore, to be paid to Stellantis. Tata Motors India has now partially ditched the high-cost associates and is now independent to develop, tune, and upgrade its engine and bring down the cost of the components. As per reports, the new 2.0-liter diesel engine might be tuned for different power outputs. Tata is likely to develop the FAM B 2.0-l diesel engine to give out around 180 bhp, and another version tuned to deliver 150 bhp, for the top trim and the lower trim models, respectively. While the exact timeline of this engine project undertaken by Tata has not been announced yet, we expect the brand to lay down the plans and development by the year-end.
Yahoo
23-05-2025
- Business
- Yahoo
Asian Penny Stocks: Zhejiang Shibao And 2 Promising Market Contenders
As global markets react positively to the recent U.S.-China tariff pause, investor sentiment has been buoyed by easing trade tensions and slowing inflation. In this context, penny stocks—often representing smaller or newer companies—remain a compelling area for potential growth despite being considered a niche investment. By focusing on those with strong financial health and solid fundamentals, investors can uncover opportunities in these underappreciated stocks that may offer stability alongside significant upside potential. Name Share Price Market Cap Financial Health Rating T.A.C. Consumer (SET:TACC) THB4.48 THB2.69B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.425 SGD172.25M ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.18 SGD35.86M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.14 SGD8.42B ★★★★★☆ BRC Asia (SGX:BEC) SGD3.14 SGD861.46M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$1.87 HK$3.23B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.42 HK$50.6B ★★★★★★ Lever Style (SEHK:1346) HK$1.15 HK$725.59M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.20 HK$2B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.16 HK$1.8B ★★★★★★ Click here to see the full list of 1,171 stocks from our Asian Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang Shibao Company Limited, with a market cap of HK$9.17 billion, engages in the research, design, development, production, and sale of automotive steering systems and accessories in the People's Republic of China. Operations: No specific revenue segments are reported for Zhejiang Shibao Company Limited. Market Cap: HK$9.17B Zhejiang Shibao has demonstrated strong financial performance, with earnings growing significantly by 95.8% over the past year, outpacing the Auto Components industry. The company's debt is well-covered by operating cash flow, and it maintains more cash than total debt, indicating robust financial health. Its seasoned management and board of directors add to its stability. Despite these strengths, Zhejiang Shibao's share price has been highly volatile recently and its Return on Equity remains low at 9.8%. Recent dividend increases signal confidence in sustained profitability as evidenced by improved net profit margins from last year. Get an in-depth perspective on Zhejiang Shibao's performance by reading our balance sheet health report here. Examine Zhejiang Shibao's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★★★ Overview: JBM (Healthcare) Limited is an investment holding company involved in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products across Hong Kong, Macau, Mainland China, and internationally with a market cap of approximately HK$2.11 billion. Operations: The company generates revenue from three main segments: Branded Medicines (HK$215.22 million), Health and Wellness Products (HK$85.81 million), and Proprietary Chinese Medicines (HK$419.51 million). Market Cap: HK$2.11B JBM (Healthcare) Limited shows promising growth potential with earnings forecasted to grow 13.27% annually. The company has demonstrated significant earnings growth of 67.2% over the past year, surpassing industry averages, and maintains high-quality past earnings. Its financial health is solid, with short-term assets exceeding liabilities and more cash than total debt, ensuring interest payments are well-covered by EBIT. Management and board members bring experience to the table, while stable weekly volatility adds a layer of predictability for investors. Despite a low Return on Equity of 16.1%, JBM trades significantly below estimated fair value, highlighting potential investment appeal in the penny stock space. Click here and access our complete financial health analysis report to understand the dynamics of JBM (Healthcare). Assess JBM (Healthcare)'s future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Food Empire Holdings Limited is an investment holding company that manufactures and distributes food and beverage products across Russia, Ukraine, Kazakhstan, CIS markets, South-East Asia, South Asia, and internationally with a market cap of SGD929.20 million. Operations: The company's revenue is primarily derived from South Asia ($264.76 million), Russia ($147.23 million), Ukraine, Kazakhstan and CIS markets ($124.68 million), and South-East Asia ($83.01 million). Market Cap: SGD929.2M Food Empire Holdings Limited, with a market cap of SGD929.20 million, has shown resilience in its financial structure despite recent negative earnings growth. The company's short-term assets significantly exceed both its short and long-term liabilities, indicating strong liquidity. While the Return on Equity is relatively low at 17.9%, debt levels are well-managed with cash exceeding total debt and interest payments covered by EBIT multiple times over. Recent strategic moves include securing a USD10 million loan for a new manufacturing facility in Kazakhstan, expected to enhance production capabilities and export potential in Central Asia. However, dividend sustainability remains questionable as it isn't well-covered by free cash flows. Navigate through the intricacies of Food Empire Holdings with our comprehensive balance sheet health report here. Review our growth performance report to gain insights into Food Empire Holdings' future. Explore the 1,171 names from our Asian Penny Stocks screener here. Looking For Alternative Opportunities? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 28 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1057 SEHK:2161 and SGX:F03. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22-05-2025
- Business
- Yahoo
Asian Penny Stocks: Zhejiang Shibao And 2 Promising Market Contenders
As global markets react positively to the recent U.S.-China tariff pause, investor sentiment has been buoyed by easing trade tensions and slowing inflation. In this context, penny stocks—often representing smaller or newer companies—remain a compelling area for potential growth despite being considered a niche investment. By focusing on those with strong financial health and solid fundamentals, investors can uncover opportunities in these underappreciated stocks that may offer stability alongside significant upside potential. Name Share Price Market Cap Financial Health Rating T.A.C. Consumer (SET:TACC) THB4.48 THB2.69B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.425 SGD172.25M ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.18 SGD35.86M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.14 SGD8.42B ★★★★★☆ BRC Asia (SGX:BEC) SGD3.14 SGD861.46M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$1.87 HK$3.23B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.42 HK$50.6B ★★★★★★ Lever Style (SEHK:1346) HK$1.15 HK$725.59M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.20 HK$2B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.16 HK$1.8B ★★★★★★ Click here to see the full list of 1,171 stocks from our Asian Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang Shibao Company Limited, with a market cap of HK$9.17 billion, engages in the research, design, development, production, and sale of automotive steering systems and accessories in the People's Republic of China. Operations: No specific revenue segments are reported for Zhejiang Shibao Company Limited. Market Cap: HK$9.17B Zhejiang Shibao has demonstrated strong financial performance, with earnings growing significantly by 95.8% over the past year, outpacing the Auto Components industry. The company's debt is well-covered by operating cash flow, and it maintains more cash than total debt, indicating robust financial health. Its seasoned management and board of directors add to its stability. Despite these strengths, Zhejiang Shibao's share price has been highly volatile recently and its Return on Equity remains low at 9.8%. Recent dividend increases signal confidence in sustained profitability as evidenced by improved net profit margins from last year. Get an in-depth perspective on Zhejiang Shibao's performance by reading our balance sheet health report here. Examine Zhejiang Shibao's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★★★ Overview: JBM (Healthcare) Limited is an investment holding company involved in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products across Hong Kong, Macau, Mainland China, and internationally with a market cap of approximately HK$2.11 billion. Operations: The company generates revenue from three main segments: Branded Medicines (HK$215.22 million), Health and Wellness Products (HK$85.81 million), and Proprietary Chinese Medicines (HK$419.51 million). Market Cap: HK$2.11B JBM (Healthcare) Limited shows promising growth potential with earnings forecasted to grow 13.27% annually. The company has demonstrated significant earnings growth of 67.2% over the past year, surpassing industry averages, and maintains high-quality past earnings. Its financial health is solid, with short-term assets exceeding liabilities and more cash than total debt, ensuring interest payments are well-covered by EBIT. Management and board members bring experience to the table, while stable weekly volatility adds a layer of predictability for investors. Despite a low Return on Equity of 16.1%, JBM trades significantly below estimated fair value, highlighting potential investment appeal in the penny stock space. Click here and access our complete financial health analysis report to understand the dynamics of JBM (Healthcare). Assess JBM (Healthcare)'s future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Food Empire Holdings Limited is an investment holding company that manufactures and distributes food and beverage products across Russia, Ukraine, Kazakhstan, CIS markets, South-East Asia, South Asia, and internationally with a market cap of SGD929.20 million. Operations: The company's revenue is primarily derived from South Asia ($264.76 million), Russia ($147.23 million), Ukraine, Kazakhstan and CIS markets ($124.68 million), and South-East Asia ($83.01 million). Market Cap: SGD929.2M Food Empire Holdings Limited, with a market cap of SGD929.20 million, has shown resilience in its financial structure despite recent negative earnings growth. The company's short-term assets significantly exceed both its short and long-term liabilities, indicating strong liquidity. While the Return on Equity is relatively low at 17.9%, debt levels are well-managed with cash exceeding total debt and interest payments covered by EBIT multiple times over. Recent strategic moves include securing a USD10 million loan for a new manufacturing facility in Kazakhstan, expected to enhance production capabilities and export potential in Central Asia. However, dividend sustainability remains questionable as it isn't well-covered by free cash flows. Navigate through the intricacies of Food Empire Holdings with our comprehensive balance sheet health report here. Review our growth performance report to gain insights into Food Empire Holdings' future. Explore the 1,171 names from our Asian Penny Stocks screener here. Looking For Alternative Opportunities? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 28 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1057 SEHK:2161 and SGX:F03. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Business
- Yahoo
3 Asian Penny Stocks With Market Caps Under US$200M To Consider
As Asian markets react to the recent de-escalation of trade tensions between the U.S. and China, there is a renewed sense of optimism among investors. This environment provides an intriguing backdrop for exploring penny stocks, which, despite their vintage terminology, continue to represent opportunities in smaller or emerging companies. By focusing on those with strong financial foundations, investors may uncover potential value and growth prospects within these often-overlooked segments of the market. Name Share Price Market Cap Financial Health Rating T.A.C. Consumer (SET:TACC) THB4.48 THB2.69B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.40 SGD162.12M ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.186 SGD37.05M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.20 SGD8.66B ★★★★★☆ BRC Asia (SGX:BEC) SGD3.11 SGD853.23M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$1.91 HK$3.3B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.60 HK$52.66B ★★★★★★ Lever Style (SEHK:1346) HK$1.19 HK$750.83M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.31 HK$2.19B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.17 HK$1.81B ★★★★★★ Click here to see the full list of 1,175 stocks from our Asian Penny Stocks screener. We'll examine a selection from our screener results. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: The Warehouse Group Limited, along with its subsidiaries, operates retail stores in New Zealand and has a market capitalization of approximately NZ$310.82 million. Operations: The company's revenue is primarily derived from its retail operations in New Zealand, with NZ$1.77 billion from The Warehouse, NZ$1.01 billion from Noel Leeming, and NZ$223.83 million from Warehouse Stationery. Market Cap: NZ$310.82M Warehouse Group's recent earnings report shows a turnaround, with net income of NZ$11.79 million for the half-year, compared to a loss last year. Despite being unprofitable overall, its debt management is strong, with debt covered by operating cash flow and reduced leverage over five years. The stock trades below estimated fair value and offers good relative value compared to peers. However, challenges remain as short-term liabilities exceed assets and interest coverage is weak. The management team's inexperience could be a concern for investors seeking stability in this penny stock environment. Navigate through the intricacies of Warehouse Group with our comprehensive balance sheet health report here. Evaluate Warehouse Group's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Steve Leung Design Group Limited provides interior design services in the People's Republic of China, Hong Kong, and Macau, with a market cap of HK$1.19 billion. Operations: The company's revenue is primarily derived from three segments: Steve Leung Design (HK$220.55 million), Steve Leung Lifestyle (HK$112.67 million), and Jangho Design (HK$48.25 million). Market Cap: HK$1.19B Steve Leung Design Group has shown a positive shift by achieving profitability, with net income of HK$1.81 million for 2024, compared to a previous loss. The company's short-term assets significantly exceed both short and long-term liabilities, indicating strong liquidity. Debt management is robust, with cash exceeding total debt and interest payments well-covered by EBIT. However, the return on equity remains low at 0.4%, and earnings have declined significantly over the past five years despite recent profitability gains. The board's experience adds stability, though management tenure data is insufficient to assess leadership depth fully. Recent regulatory updates align with evolving listing requirements. Click here to discover the nuances of Steve Leung Design Group with our detailed analytical financial health report. Examine Steve Leung Design Group's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Far East Hospitality Trust, listed on the SGX-ST, operates as a Singapore-focused hotel and serviced residence hospitality trust with a market cap of SGD1.14 billion. Operations: The trust generates revenue primarily from its Hotels and Serviced Residences segment, which accounts for SGD91.36 million, and from Retail Units, Offices and Others, contributing SGD17.34 million. Market Cap: SGD1.14B Far East Hospitality Trust, with a market cap of SGD1.14 billion, has experienced stable weekly volatility over the past year. Despite a significant earnings decline last year, its long-term debt management shows improvement with a reduced net debt to equity ratio from 59.3% to 38.7% over five years. The trust's expansion into Japan through the acquisition of Four Points by Sheraton in Nagoya marks its first overseas venture, aiming to diversify geographically and reduce concentration risks while maintaining Singapore as its core focus. However, short-term assets do not cover long-term liabilities, posing potential financial challenges ahead. Dive into the specifics of Far East Hospitality Trust here with our thorough balance sheet health report. Examine Far East Hospitality Trust's earnings growth report to understand how analysts expect it to perform. Jump into our full catalog of 1,175 Asian Penny Stocks here. Contemplating Other Strategies? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NZSE:WHS SEHK:2262 and SGX:Q5T. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
09-04-2025
- Business
- Yahoo
Yangzijiang Shipbuilding (Holdings) Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Revenue: CN¥26.5b (up 10% from FY 2023). Net income: CN¥6.63b (up 62% from FY 2023). Profit margin: 25% (up from 17% in FY 2023). EPS: CN¥1.68 (up from CN¥1.04 in FY 2023). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue missed analyst estimates by 6.8%. Earnings per share (EPS) exceeded analyst estimates by 3.9%. The primary driver behind last 12 months revenue was the Shipbuilding segment contributing a total revenue of CN¥25.2b (95% of total revenue). Notably, cost of sales worth CN¥18.9b amounted to 71% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to CN¥639.8m (66% of total expenses). Explore how BS6's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Machinery industry in Singapore. Performance of the Singaporean Machinery industry. The company's shares are down 20% from a week ago. While earnings are important, another area to consider is the balance sheet. See our latest analysis on Yangzijiang Shipbuilding (Holdings)'s balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
